CDK9-IN-36
CDK9-IN-36 (T7) is a potent and selective CDK9 inhibitor (IC50 = 1.2 nM) with favorable metabolic stability. It demonstrates anti-proliferative effects in vitro against Osimertinib-resistant NSCLC cells by targeting Mcl-1 and inducing apoptosis, and shows in vivo antitumor efficacy in xenograft models.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin
Molecular Formula
C30H33F2N5O4
Molecular Weight
565.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6316915-01 0.2 mL
LRIG2, CT (LRIG2, KIAA0806, LIG2, Leucine-rich repeats and immunoglobulin-like domains protein 2) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6316915-02 5x 0.2 mL
LRIG2, CT (LRIG2, KIAA0806, LIG2, Leucine-rich repeats and immunoglobulin-like domains protein 2) (Azide free) (HRP)
Sign In for Pricing
View Details 